Register Login

Antiplatelet Therapy

Platelet-inflammation Interactions

Click here for a provocative open-access article describing the now established relationship between platelets and inflammatory processes: Escaig R, Kreutz L, Kaiser R, Nicolai L. Platelet effector functions in inflammation. Res Pract Thromb Haemost. 2026;10:103412. doi: 10.1016/j.rpth.2026.103412. PMID: 42027308; PMCID: PMC13100282. Abstract A State of the Art lecture titled “Platelet effector functions in inflammation” was […]
read more

A Molecular Approach to Assess Platelet Hyperreactivity

Friend Ed Groenendal forwarded this UPI summary of a molecular approach correlating evidence of hyperresponsive platelets to major adverse cardiac or limb events. The investigators started with aggregometry-defined platelet hyperreactivity to apply a transcriptome-based platelet reactivity expression score (PRESS). Click below to see the detailed open-access article describing the development and application of the PRESS. […]
read more

Primary CVD Disease: Is Low Dose ASA Effective?

Thanks to Dean Willett, Precision BioLogic Inc, for pointing me to this October 12, 2021 US Preventive Services Task Force release, “Aspirin Use to Prevent Cardiovascular Disease: Preventive Medication,” which recommends against daily low-dose aspirin as a means to reduce the risk of cardiovascular disease, ischemic stroke, and colorectal cancer regardless of age or comorbities. […]
read more